OBJECTIVES: Arginine deficiency may contribute to microvascular dysfunction, but previous studies suggest that arginine supplementation may be harmful in sepsis. Systemic arginine availability can be estimated by measuring the ratio of arginine to its endogenous inhibitors, asymmetric and symmetric dimethylarginine. We hypothesized that the arginine-to-dimethylarginine ratio is reduced in patients with severe sepsis and associated with severity of illness and outcomes. DESIGN: Case-control and prospective cohort study. SETTING: Medical and surgical intensive care units of an academic medical center. PATIENTS AND SUBJECTS: One hundred nine severe sepsis and 50 control subjects. MEASUREMENTS AND MAIN RESULTS: Plasma and urine were obtained in control subjects and within 48 hrs of diagnosis in severe sepsis patients. The arginine-to-dimethylarginine ratio was higher in control subjects vs. sepsis patients (median, 95; interquartile range, 85-114; vs. median, 34; interquartile range, 24-48; p < .001) and in hospital survivors vs. nonsurvivors (median, 39; interquartile range, 26-52; vs. median, 27; interquartile range, 19-32; p = .004). The arginine-to-dimethylarginine ratio was correlated with Acute Physiology and Chronic Health Evaluation II score (Spearman's correlation coefficient [ρ] = - 0.40; p < .001) and organ-failure free days (ρ = 0.30; p = .001). A declining arginine-to-dimethylarginine ratio was independently associated with hospital mortality (odds ratio, 1.63 per quartile; 95% confidence interval, 1.00-2.65; p = .048) and risk of death over the course of 6 months (hazard ratio, 1.41 per quartile; 95% confidence interval, 1.01-1.98; p = .043). The arginine-to-dimethylarginine ratio was correlated with the urinary nitrate-to-creatinine ratio (ρ = 0.46; p < .001). CONCLUSIONS: The arginine-to-dimethylarginine ratio is associated with severe sepsis, severity of illness, and clinical outcomes. The arginine-to-dimethylarginine ratio may be a useful biomarker, and interventions designed to augment systemic arginine availability in severe sepsis may still be worthy of investigation.
OBJECTIVES:Arginine deficiency may contribute to microvascular dysfunction, but previous studies suggest that arginine supplementation may be harmful in sepsis. Systemic arginine availability can be estimated by measuring the ratio of arginine to its endogenous inhibitors, asymmetric and symmetric dimethylarginine. We hypothesized that the arginine-to-dimethylarginine ratio is reduced in patients with severe sepsis and associated with severity of illness and outcomes. DESIGN: Case-control and prospective cohort study. SETTING: Medical and surgical intensive care units of an academic medical center. PATIENTS AND SUBJECTS: One hundred nine severe sepsis and 50 control subjects. MEASUREMENTS AND MAIN RESULTS: Plasma and urine were obtained in control subjects and within 48 hrs of diagnosis in severe sepsispatients. The arginine-to-dimethylarginine ratio was higher in control subjects vs. sepsispatients (median, 95; interquartile range, 85-114; vs. median, 34; interquartile range, 24-48; p < .001) and in hospital survivors vs. nonsurvivors (median, 39; interquartile range, 26-52; vs. median, 27; interquartile range, 19-32; p = .004). The arginine-to-dimethylarginine ratio was correlated with Acute Physiology and Chronic Health Evaluation II score (Spearman's correlation coefficient [ρ] = - 0.40; p < .001) and organ-failure free days (ρ = 0.30; p = .001). A declining arginine-to-dimethylarginine ratio was independently associated with hospital mortality (odds ratio, 1.63 per quartile; 95% confidence interval, 1.00-2.65; p = .048) and risk of death over the course of 6 months (hazard ratio, 1.41 per quartile; 95% confidence interval, 1.01-1.98; p = .043). The arginine-to-dimethylarginine ratio was correlated with the urinary nitrate-to-creatinine ratio (ρ = 0.46; p < .001). CONCLUSIONS: The arginine-to-dimethylarginine ratio is associated with severe sepsis, severity of illness, and clinical outcomes. The arginine-to-dimethylarginine ratio may be a useful biomarker, and interventions designed to augment systemic arginine availability in severe sepsis may still be worthy of investigation.
Authors: G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher Journal: N Engl J Med Date: 2001-03-08 Impact factor: 91.245
Authors: Dan E Berkowitz; Ron White; Dechun Li; Khalid M Minhas; Amy Cernetich; Soonyul Kim; Sean Burke; Artin A Shoukas; Daniel Nyhan; Hunter C Champion; Joshua M Hare Journal: Circulation Date: 2003-09-29 Impact factor: 29.690
Authors: Mary Anne M Morgan; Lauren M Frasier; Judith C Stewart; Cynthia M Mack; Michael S Gough; Brian T Graves; Michael J Apostolakos; Kathleen P Doolin; Denise C Darling; Mark W Frampton; Anthony P Pietropaoli Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: R J Nijveldt; T Teerlink; B Van Der Hoven; M P C Siroen; D J Kuik; J A Rauwerda; P A M van Leeuwen Journal: Clin Nutr Date: 2003-02 Impact factor: 7.324
Authors: Friedrich Mittermayer; Khodadad Namiranian; Johannes Pleiner; Georg Schaller; Michael Wolzt Journal: Clin Sci (Lond) Date: 2004-06 Impact factor: 6.124
Authors: Christopher W Seymour; Sachin Yende; Melanie J Scott; John Pribis; Robert P Mohney; Lauren N Bell; Yi-Fan Chen; Brian S Zuckerbraun; William L Bigbee; Donald M Yealy; Lisa Weissfeld; John A Kellum; Derek C Angus Journal: Intensive Care Med Date: 2013-05-15 Impact factor: 17.440
Authors: Carlijn T I de Betue; Koen F M Joosten; Nicolaas E P Deutz; Anita C E Vreugdenhil; Dick A van Waardenburg Journal: Am J Clin Nutr Date: 2013-08-14 Impact factor: 7.045
Authors: Orren Wexler; Mary A M Morgan; Michael S Gough; Sherry D Steinmetz; Cynthia M Mack; Denise C Darling; Kathleen P Doolin; Michael J Apostolakos; Brian T Graves; Mark W Frampton; Xucai Chen; Anthony P Pietropaoli Journal: Crit Care Date: 2012-12-12 Impact factor: 9.097
Authors: Thorsten Brenner; Thomas H Fleming; Claudia Rosenhagen; Ute Krauser; Markus Mieth; Thomas Bruckner; Eike Martin; Peter P Nawroth; Markus A Weigand; Angelika Bierhaus; Stefan Hofer Journal: Mediators Inflamm Date: 2012-05-06 Impact factor: 4.711
Authors: Greg Tsang; Michael B Insel; Justin M Weis; Mary Anne M Morgan; Michael S Gough; Lauren M Frasier; Cynthia M Mack; Kathleen P Doolin; Brian T Graves; Michael J Apostolakos; Anthony P Pietropaoli Journal: Crit Care Date: 2016-10-21 Impact factor: 9.097
Authors: Marco B Hansen; Lars S Rasmussen; Peter Garred; Katrine Pilely; Anna M Wahl; Anders Perner; Martin B Madsen; Elise R Hedegaard; Ulf Simonsen; Ole Hyldegaard Journal: Shock Date: 2018-06 Impact factor: 3.454